The NIHR Clinical Research Network is delighted to announce the winners of the research awards run in partnership with the Royal College of Emergency Medicine (RCEM).
Two flagship, NIHR-supported studies - REMAP-CAP and RECOVERY - have found no evidence of benefit from convalescent plasma as a treatment for hospitalised patients with COVID-19.
Researchers have developed a new risk stratification tool that can accurately predict the likelihood of deterioration in adults hospitalised with COVID-19.
The House of Commons Science and Technology Committee has today published its analysis of the way the Government has received, and applied, scientific evidence and advice during the first period of the coronavirus pandemic.
The Medicines & Healthcare Products Regulatory Agency (MHRA) has approved use of the COVID-19 vaccine developed by the University of Oxford and AstraZeneca for people in the UK.
A study led by NIHR-funded researchers investigating ways to reduce the impacts of gambling-related harms are today published in the Lancet
The NIHR-supported RECOVERY trial has found no clinical benefit from the antibiotic azithromycin for hospitalised patients with severe COVID-19.
Ethnic minority healthcare workers are more likely to have built up antibodies to COVID-19, a team of NIHR-supported researchers have found.
Over six hundred thousand participants have now taken part in NIHR-supported urgent public health research into Covid-19, in just over eight months.
Community nurses from across the nation, led by a group of NIHR 70@70 senior nurse research leaders, are launching a new project to give patients, carers and healthcare professionals the opportunity to have their say about the future of community nursing research.
The NIHR-supported Novavax Phase 3 COVID-19 vaccine trial has achieved its recruitment target just two months after opening in the UK - with 15,203 volunteers from across the country recruited in record time.
The NIHR-supported PRINCIPLE trial is to start investigating the inhaled corticosteroid budesonide to find out if it can help treat COVID-19 in patients who aren’t in hospital.
NIHR responds to the announcement by the Chancellor of £1.3 billion to continue the 'world-leading' work of the NIHR and Genomics England.
A collaboration between one of the NIHR’s new National Patient Recruitment Centres and Enteromed has led to rapid recruitment to one of the first fully virtual interventional clinical trials conducted in England.
A UK study participant is the first in the world to receive a new COVID-19 monoclonal antibody treatment, developed by AstraZeneca.
The Clinical Research Delivery team at Calderdale & Huddersfield NHS Foundation Trust has won the 2020 Nursing Times award for Clinical Research Nursing.
The NIHR’s Research for Social Care call (RfSC) has funded £2.19 million of new research into adult social care, as part of NIHR’s commitment to improving social care through high quality evidence and building capacity for research in this field.
The NIHR has launched five new National Patient Recruitment Centres (NPRCs) to enable more late phase commercial clinical research to be delivered within the NHS and make it easier for people to take part in studies.
The NIHR and UK Research and Innovation (UKRI) have launched a £20m joint research call to fund ambitious and comprehensive research into the longer term physical and mental effects of COVID-19 in non-hospitalised individuals.
New research supported by NIHR has reviewed evidence in scientific publications with data, on the effect of ethnicity on clinical outcomes in patients with COVID-19.
Severe COVID-19 infection appears rare in newborn babies, suggests a new study funded by NIHR.
NIHR supported research shows robust T cell immunity is likely to be present for at least six months after asymptomatic, mild or moderate coronavirus infection.
An online training and support resource developed by the World Health Organisation (WHO) for family and friends supporting people living with dementia is to be assessed for use in the UK for the first time, in a new study funded by the NIHR.
Researchers behind a leading NIHR-funded study showing a simple finger-prick test could help unnecessary prescribing of antibiotics among patients with chronic obstructive pulmonary disease (COPD), have won a prestigious healthcare award.
A model that can calculate a person’s risk of becoming infected and then seriously ill due to COVID-19 has been shown to accurately estimate risk during the first wave of the pandemic in England, in new research funded by the NIHR.
